| NISSIN-MEDICAL-INDUSTRIES-CO-LTD |
NISSIN-MEDICAL-INDUSTRIES-CO-LTD |
92%
|
we have been a supplier to Nissin Medical Industries Co., Ltd (“Nissin”), our largest dealer and sole distributor in Japan, since 2006. |
| WFOE |
WFOE |
90%
|
WFOE provides Changzhou Zhongjin with marketing, technical support, consulting services and management services relating to its day-to-day business operations and management, on an exclusive basis. |
| JIANGSU-CHANGZHOU-ZHONGJIAN-KANGLU-INFORMATION-T |
JIANGSU-CHANGZHOU-ZHONGJIAN-KANGLU-INFORMATION-T |
85%
|
Industrial Development (Shanghai) Co., Ltd. An entity controlled by the CEO - - 1,371 Zhongjin Jingau Rehabilitation Equipment (Beijing) Co. Ltd. An entity controlled by the CEO - - 325 Total deferre… |
| JIANGSU-ZHONGJIN-KANGLU-INFORMATION-TECHNOLOGY-C |
JIANGSU-ZHONGJIN-KANGLU-INFORMATION-TECHNOLOGY-C |
85%
|
ties controlled by the Company’s CEO and used for working capital during the Company’s normal course of business. These advances are non-interest bearing and due on demand. F- 27 NOTE 10 — RELATED PA… |
| JINMED-INTERNATIONAL-CO-LTD |
JINMED-INTERNATIONAL-CO-LTD |
85%
|
ties controlled by the Company’s CEO and used for working capital during the Company’s normal course of business. These advances are non-interest bearing and due on demand. F- 27 NOTE 10 — RELATED PA… |
| CHANGZHOU-ELECTRIC-CO-LTD |
CHANGZHOU-ELECTRIC-CO-LTD |
62%
|
October 1, 2023, we adopted Accounting Standards Update 2016-13 “Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments,” which replaces the incurred… |
| CHANGZHOU-ZHONGJIAN-KANGLU-INFORMATION-TECHNOLOG |
CHANGZHOU-ZHONGJIAN-KANGLU-INFORMATION-TECHNOLOG |
62%
|
NOTE 10 — RELATED PARTY TRANSACTIONS (continued) c. Deferred revenue – related parties Deferred revenue – related parties consist of the following: Name Related party relationship September 30, 2024 … |
| JIANGSU-YUYUE-MEDICAL-EQUIPMENT-CO-LTD |
JIANGSU-YUYUE-MEDICAL-EQUIPMENT-CO-LTD |
62%
|
ribution platform where we can promote our products directly to the end users. Competition The wheelchair and living aids products markets in both Japan and China are complex and attractive markets c… |
| NISSIN-CO-LTD |
NISSIN-CO-LTD |
62%
|
NOTE 16 — SUBSEQUENT EVENTS On December 5, 2024, Changzhou Zhongjin entered into a repayment agreement with its customer Nissin Co., Ltd. (“Nissin Korea”). Pursuant to the agreement, the accounts rec… |
| NISSIN-MEDICAL-VIETNAM-CO-LTD |
NISSIN-MEDICAL-VIETNAM-CO-LTD |
62%
|
a number of them. For example, we have been a supplier to Nissin Medical Industries Co., Ltd (“Nissin”), our largest dealer and sole distributor in Japan, since 2006. Despite the number of dealers we… |
| SHANGHAI-CO-LTD |
SHANGHAI-CO-LTD |
62%
|
tform, which has enabled us to directly promote our products to the end users. Competition The wheelchair and living aids products markets in both Japan and China are complex and attractive markets c… |
| SHANGHAI-JIEKAIYANG-MEDICAL-EQUIPMENT-CO-LTD |
SHANGHAI-JIEKAIYANG-MEDICAL-EQUIPMENT-CO-LTD |
62%
|
ribution platform where we can promote our products directly to the end users. Competition The wheelchair and living aids products markets in both Japan and China are complex and attractive markets c… |
| SHANGHAI-SITUMA-INTELLIGENT-TECHNOLOGY-CO-LTD |
SHANGHAI-SITUMA-INTELLIGENT-TECHNOLOGY-CO-LTD |
62%
|
NOTE 10 — RELATED PARTY TRANSACTIONS (continued) c. Deferred revenue – related parties Deferred revenue – related parties consist of the following: Name Related party relationship September 30, 2024 … |
